05/20/2025
6:35 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
6:13 PM | Corcept Therapeutics (Issuer)
MAHONEY DAVID L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
1:29 PM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2025
1:32 PM | Corcept Therapeutics (Subject)
MAHONEY DAVID L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2025
12:40 PM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2025
4:51 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2025
9:40 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2025
7:20 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
7:33 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
7:26 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
7:28 PM | BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CORT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Corcept Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/02/2025
2:52 PM | Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/23/2025
6:41 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2025
6:09 AM | BlackRock, Inc. (Filed by)
Corcept Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/14/2025
4:58 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2025
9:07 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2025
7:01 PM | BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
7:08 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
7:15 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
7:20 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
2:13 PM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2025
2:23 PM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2025
2:00 PM | Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/31/2025
7:05 AM | Corcept Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2025
5:55 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
4:07 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
4:07 PM | BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2025
7:30 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
4:30 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
3:54 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
10:02 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
7:15 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:53 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:58 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:34 PM | Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:38 PM | Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:44 PM | BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:27 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
12:59 PM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
12:47 PM | BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
11:37 AM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
The 402 Dividend Achievers for 2025 (Ad) The 2025 Dividend Achievers List 📈
Discover more than 400 companies that have increased their dividends for 10 straight years. This FREE report reveals stocks that are committed to rewarding you and helping you passively boost your income. Don’t miss this valuable opportunity to build a stronger portfolio. |
03/03/2025
11:18 AM | Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2025
3:18 PM | Corcept Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2025
3:06 PM | Corcept Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2025
4:23 PM | Corcept Therapeutics (Subject)
INGALLS & SNYDER LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
8:08 PM | BELANOFF JOSEPH K (Filed by)
Corcept Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
3:40 PM | BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/13/2025
7:20 PM | Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
7:26 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
10:36 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
12:33 PM | Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
12:17 PM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
3:14 PM | Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
7:20 PM | Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
6:30 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
9:49 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025
6:59 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:15 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:24 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
5:03 PM | BAKER G LEONARD JR (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
11:03 AM | Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2025
10:52 AM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2025
10:58 AM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/31/2024
3:41 PM | Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
4:20 PM | Corcept Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
3:59 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
9:00 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
5:13 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
5:16 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
1:36 PM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2024
10:41 AM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2024
7:06 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
6:48 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
11:55 AM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/30/2024
3:09 PM | Corcept Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
3:12 PM | Corcept Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/03/2024
3:27 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
6:55 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
11:55 AM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/01/2024
11:44 AM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2024
5:34 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:27 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:24 PM | Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:57 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:04 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:08 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
10:33 AM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
4:59 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
2:37 PM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
6:10 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
5:31 PM | Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
7 Tiny “Trump Stocks” Poised for Large Moves (Ad) 7 Cheap and Good Stocks to Buy Now 💰
Discover 7 massively discounted stocks ready for growth. This free report features companies like Stock #1, a niche AI leader in voice recognition technology, and Stock #6, an energy drink company rapidly expanding across major retailers. Don’t miss out on these incredible opportunities. |
08/05/2024
5:56 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2024
3:42 PM | BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
12:36 PM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
10:26 AM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/29/2024
3:13 PM | Corcept Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/03/2024
4:13 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
4:16 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
3:54 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
3:54 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy CORT Stock Free CORT Stock Alerts